EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RNA sequencing of peripheral blood in amyotrophic lateral sclerosis reveals distinct molecular subtypes: Considerations for biomarker discovery

Natalie Grima iD, Sidong Liu iD, Dean Southwood iD, Lyndal Henden iD, Andrew Smith iD, Albert Lee iD, Dominic B Rowe iD, Susan D'Silva, Ian P Blair iD, Kelly L Williams iD

Neuropathology and Applied Neurobiology · 2023-12 · 49 (6)

DOI: 10.1111/nan.12943 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropathology and Applied Neurobiology, online erschienen am 07.11.2023. Verfasst von Natalie Grima und 9 weiteren Autor:innen. Beteiligte Einrichtung: Motor Neuron Disease Research Centre, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Au…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Neurodegenerative Diseases. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Motor Neurone Disease Research Australia, National Health and Medical Research Council, NHMRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Amyotrophic lateral sclerosis (ALS) is a heterogeneous neurodegenerative disease with limited therapeutic options. A key factor limiting the development of effective therapeutics is the lack of disease biomarkers. We sought to assess whether biomarkers for diagnosis, prognosis or cohort stratification could be identified by RNA sequencing (RNA‐seq) of ALS patient peripheral blood.

Methods

Whole blood RNA‐seq data were generated for 96 Australian sporadic ALS (sALS) cases and 48 healthy controls (NCBI GEO accession GSE234297). Differences in sALS–control gene expression, transcript usage and predicted leukocyte proportions were assessed, with pathway analysis used to predict the activity state of biological processes. Weighted Gene Co‐expression Network Analysis (WGCNA) and machine learning algorithms were applied to search for diagnostic and prognostic gene expression patterns. Unsupervised clustering analysis was employed to determine whether sALS patient subgroups could be detected.

Results

Two hundred and forty‐five differentially expressed genes were identified in sALS patients relative to controls, with enrichment of immune, metabolic and stress‐related pathways. sALS patients also demonstrated switches in transcript usage across a small set of genes. We established a classification model that distinguished sALS patients from controls with an accuracy of 78% (sensitivity: 79%, specificity: 75%) using the expression of 20 genes. Clustering analysis identified four patient subgroups with gene expression signatures and immune cell proportions reflective of distinct peripheral effects.

Conclusions

Our findings suggest that peripheral blood RNA‐seq can identify diagnostic biomarkers and distinguish molecular subtypes of sALS patients however, its prognostic value requires further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisNeurodegenerative DiseasesHumansAustraliaBiomarkersSequence Analysis, RNA

Stichwörter der Autor:innen

RNA-seqamyotrophic lateral sclerosisbiomarkerferroptosisimmune responsemetabolismperipheral bloodtranscriptome

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Motor Neuron Disease Research Centre, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.
  • Centre for Health Informatics, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.

ORCID-Profile: Natalie Grima, Sidong Liu, Dean Southwood, Lyndal Henden, Andrew Smith, Albert Lee, Dominic B Rowe, Ian P Blair, Kelly L Williams

Förderung

  • Motor Neurone Disease Research Australia
  • National Health and Medical Research Council
  • NHMRC
  • FightMND

Zitieren

APA

Grima, N., Liu, S., Southwood, D., Henden, L., Smith, A., Lee, A., Rowe, D. B., D'Silva, S., Blair, I. P., & Williams, K. L. (2023). RNA sequencing of peripheral blood in amyotrophic lateral sclerosis reveals distinct molecular subtypes: Considerations for biomarker discovery. Neuropathology and Applied Neurobiology, 49(6). https://doi.org/10.1111/nan.12943

Vancouver

Grima N, Liu S, Southwood D, Henden L, Smith A, Lee A, et al. RNA sequencing of peripheral blood in amyotrophic lateral sclerosis reveals distinct molecular subtypes: Considerations for biomarker discovery. Neuropathology and Applied Neurobiology. 2023;49(6). doi:10.1111/nan.12943

BibTeX
@article{Grima2023,
  author = {Grima, Natalie and Liu, Sidong and Southwood, Dean and Henden, Lyndal and Smith, Andrew and Lee, Albert and Rowe, Dominic B and D'Silva, Susan and Blair, Ian P and Williams, Kelly L},
  title = {RNA sequencing of peripheral blood in amyotrophic lateral sclerosis reveals distinct molecular subtypes: Considerations for biomarker discovery},
  journal = {Neuropathology and Applied Neurobiology},
  year = {2023},
  volume = {49},
  number = {6},
  doi = {10.1111/nan.12943}
}
Kostenlos starten →